Double maintains 1 strategies that include MDGL - Madrigal Pharmaceuticals, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PTH | 42.83% | $99.23M | 0.6% |
XBI | 40.40% | $4.93B | 0.35% |
ARKG | 36.49% | $951.31M | 0.75% |
IBB | 36.42% | $5.25B | 0.45% |
GNOM | 35.78% | $40.81M | 0.5% |
FFTY | 34.78% | $68.85M | 0.8% |
FBT | 34.02% | $1.03B | 0.56% |
SIXG | 33.14% | $572.12M | 0.3% |
IWO | 32.54% | $11.46B | 0.24% |
BBH | 32.37% | $331.37M | 0.35% |
AIPI | 32.25% | $291.40M | 0.65% |
PBE | 32.20% | $220.56M | 0.58% |
CLOU | 31.74% | $362.58M | 0.68% |
ROBT | 31.72% | $462.20M | 0.65% |
SECT | 31.70% | $2.01B | 0.78% |
FDN | 31.18% | $7.01B | 0.51% |
QQQJ | 31.10% | $615.55M | 0.15% |
FEPI | 31.02% | $451.54M | 0.65% |
HEAL | 30.99% | $38.17M | 0.5% |
BOTZ | 30.94% | $2.54B | 0.68% |
Current Value
$289.531 Year Return
Current Value
$289.531 Year Return
SeekingAlpha
In Search Of A Tailwind, Sailing The Doldrums With Madrigal Pharmaceuticals
Yahoo
Exploring the Latest 13F Filing and Investment Strategies
Finnhub
Madrigal Pharmaceuticals ESG Fact Sheet Last Updated: May 14, 2025 About Madrigal Pharmaceuticals: Madrigal Pharmaceuticals, Inc. is a...
Yahoo
Viking Therapeutics has a promising pipeline candidate in the fast-growing therapeutic area of weight loss. Madrigal Pharmaceuticals markets the only approved therapy for a disease whose prevalence is growing. Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns.
Finnhub
Review of Compensated MASH Cirrhosis and Rezdiffra F4c Data Presented at EASL 2025 May 13, 2025 © 2025 Madrigal Pharmaceuticals, Inc. All rights reserved. ...
Yahoo
Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL Congress65% of patients with clinically significant portal hypertension (CSPH) at baseline moved into lower risk categories by year twoPatients achieved a mean 6.7 kPa reduction in liver stiffness, which was statistically significant compared to baseline CONSHOHOCKEN, Pa., May 10, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopha
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -27.09% | $357.24M | 1.43% |
VIXY | -25.03% | $126.24M | 0.85% |
TAIL | -23.73% | $124.67M | 0.59% |
IVOL | -10.99% | $353.08M | 1.02% |
ULST | -10.73% | $632.19M | 0.2% |
SPTS | -7.03% | $5.74B | 0.03% |
TPMN | -6.97% | $31.51M | 0.65% |
TFLO | -6.56% | $7.00B | 0.15% |
IBTG | -5.78% | $1.89B | 0.07% |
STPZ | -5.47% | $452.72M | 0.2% |
UTWO | -5.00% | $384.66M | 0.15% |
XONE | -4.56% | $608.43M | 0.03% |
CARY | -4.28% | $347.36M | 0.8% |
STXT | -3.58% | $134.51M | 0.49% |
UUP | -3.55% | $280.18M | 0.77% |
AGZ | -3.32% | $608.43M | 0.2% |
VTIP | -3.25% | $14.75B | 0.03% |
CMBS | -3.22% | $428.80M | 0.25% |
IBTH | -3.17% | $1.53B | 0.07% |
SCHO | -2.75% | $10.86B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPIP | -0.05% | $987.90M | 0.12% |
SPTI | -0.05% | $8.77B | 0.03% |
FTSD | 0.07% | $212.58M | 0.25% |
USFR | 0.08% | $18.94B | 0.15% |
SCHR | -0.13% | $10.56B | 0.03% |
SHYM | 0.15% | $323.50M | 0.35% |
SHY | -0.15% | $23.88B | 0.15% |
IBTO | -0.25% | $338.89M | 0.07% |
IYK | 0.28% | $1.54B | 0.4% |
FTXG | -0.30% | $35.63M | 0.6% |
GOVT | -0.33% | $27.23B | 0.05% |
DFNM | 0.34% | $1.54B | 0.17% |
FLGV | 0.34% | $979.04M | 0.09% |
DFIP | 0.41% | $879.27M | 0.11% |
IBTM | -0.43% | $317.60M | 0.07% |
TBLL | 0.49% | $2.38B | 0.08% |
BSV | -0.56% | $38.27B | 0.03% |
SPSK | -0.58% | $307.83M | 0.5% |
GSST | 0.67% | $874.27M | 0.16% |
IEF | 0.79% | $34.40B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MGPI | -18.40% | $680.70M | -60.04% | 1.52% |
FLYW | -14.71% | $1.44B | -29.66% | 0.00% |
ANIK | -13.43% | $171.52M | -53.55% | 0.00% |
HEES | -13.43% | $3.52B | +99.11% | 1.15% |
CB | -13.22% | $117.00B | +10.17% | 1.25% |
ED | -13.00% | $38.09B | +9.73% | 3.18% |
SAFT | -12.13% | $1.24B | +5.50% | 4.36% |
ESNT | -11.92% | $6.00B | +5.03% | 1.96% |
PRA | -11.65% | $1.19B | +59.67% | 0.00% |
MCY | -11.55% | $3.45B | +5.03% | 2.07% |
WRB | -11.50% | $27.90B | +41.90% | 0.49% |
ACGL | -11.16% | $35.30B | -2.55% | 0.00% |
ZCMD | -10.96% | $30.95M | -17.18% | 0.00% |
EXC | -10.61% | $44.68B | +14.90% | 3.52% |
INGN | -9.31% | $168.58M | -27.18% | 0.00% |
AMSF | -8.87% | $908.13M | +10.96% | 3.17% |
PM | -8.78% | $271.02B | +73.72% | 3.07% |
CME | -8.49% | $100.13B | +32.10% | 3.76% |
NNN | -8.23% | $7.86B | -1.46% | 5.55% |
ACHC | -7.93% | $2.32B | -61.44% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMTL | 0.01% | $59.28M | -10.22% | 0.00% |
LI | 0.03% | $23.60B | +34.78% | 0.00% |
AEE | -0.03% | $27.27B | +32.22% | 2.77% |
SUPN | -0.04% | $1.86B | +18.36% | 0.00% |
NFG | 0.04% | $7.35B | +44.10% | 2.53% |
PRMB | -0.06% | $12.20B | +51.06% | 1.16% |
HRZN | -0.06% | - | - | 17.74% |
MGEE | 0.07% | $3.37B | +11.93% | 1.94% |
OPCH | 0.08% | $5.42B | +13.53% | 0.00% |
CINF | -0.10% | $23.47B | +26.63% | 2.21% |
SJM | 0.13% | $12.23B | +2.58% | 3.76% |
CCEC | 0.15% | $1.02B | +3.91% | 2.54% |
IIPR | -0.16% | $1.60B | -49.29% | 13.50% |
ESGR | 0.16% | $5.00B | +8.56% | 0.00% |
UFI | 0.17% | $84.83M | -26.55% | 0.00% |
PG | -0.18% | $388.35B | -1.61% | 2.47% |
PGR | -0.19% | $167.44B | +36.42% | 1.73% |
HRTG | -0.19% | $766.77M | +185.35% | 0.00% |
AQB | 0.20% | $3.19M | -57.24% | 0.00% |
YALA | 0.21% | $992.02M | +58.64% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TILE | 40.52% | $1.22B | +34.30% | 0.19% |
PRLB | 39.59% | $971.50M | +28.12% | 0.00% |
EYE | 37.02% | $1.53B | +22.66% | 0.00% |
WAT | 36.79% | $21.55B | +2.97% | 0.00% |
GSAT | 36.43% | $2.43B | +9.23% | 0.00% |
MCS | 36.24% | $519.57M | +55.64% | 1.67% |
RVMD | 35.23% | $7.54B | +2.04% | 0.00% |
COHU | 35.05% | $825.89M | -39.45% | 0.00% |
ROOT | 34.53% | $2.22B | +121.39% | 0.00% |
QTRX | 34.02% | $193.76M | -70.26% | 0.00% |
BIO | 33.91% | $6.72B | -14.65% | 0.00% |
DNTH | 33.76% | $614.58M | -22.22% | 0.00% |
KRYS | 32.42% | $3.80B | -21.15% | 0.00% |
TEAM | 32.35% | $56.47B | +20.47% | 0.00% |
MTZ | 31.89% | $12.48B | +45.35% | 0.00% |
ITRI | 31.55% | $5.24B | +7.37% | 0.00% |
TWLO | 31.22% | $17.95B | +94.47% | 0.00% |
GTLS | 31.07% | $7.64B | +5.60% | 0.00% |
RCKT | 31.05% | $738.01M | -69.32% | 0.00% |
APH | 30.99% | $104.38B | +27.46% | 0.70% |